Purchase Order W81K0223P0089
Award Date 7/25/23
Potential Completion Date 8/30/23
Potential Value $18K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $182,208 firm fixed-price purchase order to Sirtex Medical Inc. on October 1, 2025, for Y-90 resin microspheres, with performance continuing through September 30, 2026. The contract, which carries no set-aside designation, is for delivery to Fort Bliss, Texas. Sirtex Medical Inc., headquartered in Woburn, Massachusetts, specializes in innovative cancer therapies and is the primary supplier of Y-90 SIR-Spheres resin microspheres—specialized medical devices used...
- This firm-fixed-price purchase order was awarded to Sirtex Medical Inc., a for-profit medical device company, by the Defense Health Agency. The contract is for the supply of SIR-Spheres Y-90 radioactive microspheres, which are used in interventional radiology procedures to treat liver tumors and metastatic disease through internal radiation therapy. The contract has a potential value of $17,750.00 and a completion date of August 1, 2022. The contract does not have a set-aside designation. Sirtex...
- The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to Sirtex Medical Inc., a global healthcare company, to provide Yttrium-90 (Y90) radioactive microspheres for the treatment of liver cancer. The $172,415.00 contract is for the supply of Sirtex's SIR-Spheres Y-90 resin microspheres and associated medical devices to be used in interventional radiology procedures to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Sirtex Medical Inc., a global healthcare company, for the supply of SIR-SPHERES Y-90 resin microspheres. The SIR-Spheres are a targeted radiation therapy used in interventional radiology procedures to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. The contract has a potential value of $863,760.00 and a completion...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a for-profit organization based in Woburn, Massachusetts. The $37,688.00 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a specialized radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract has an ultimate completion date of September 30, 2024. Sirtex Medical Inc. has a history of providing these advanced cancer...
- The U.S. Defense Health Agency (DHA) has awarded a firm fixed-price purchase order contract to Sirtex Medical Inc., a for-profit organization, for the supply of SIRTEX Y-90 RESIN MICROSPHERES. The contract, valued at $249,986.00, is a total small business set-aside and supports the provision of specialized cancer care to veterans and military members across the federal healthcare system. Sirtex Medical Inc. has a long history of providing these medical devices and related supplies to various...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a global healthcare company, for the provision of SIR-Spheres Y-90 resin microspheres and related medical devices. The contract, valued at $18,345.00, has an ultimate completion date of January 10, 2025. The SIR-Spheres are a targeted radiation therapy used in interventional radiology procedures to treat inoperable primary and metastatic liver tumors, as well as metastatic...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a for-profit medical technology company specializing in targeted radiation treatments for cancer. The $19,448 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a radioactive medical device used in Selective Internal Radiation Therapy (SIRT) to treat liver tumors and metastatic colorectal cancer. The contract has a period of performance through March 22, 2025...
- Sirtex Medical Inc. has been awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 for the delivery of Y90 resin microspheres. The contract has a potential value of $17,415 and a completion date of September 30, 2023. There is no set-aside designation. Sirtex will provide its Sir-Spheres Y-90 resin microspheres for use in selective internal radiation therapy by VA medical facilities in the region....
- This federal contract award to Sirtex Medical Inc. is for the delivery of SIR-Spheres Y-90 resin microspheres, a medical device used in selective internal radiation therapy to treat inoperable liver cancer. The contract, awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $416,000.00. Sirtex Medical, a global healthcare company, is the prime contractor supplying these specialized radioactive spheres to the VA and DOD healthcare systems. The...